| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.836 | 16.891 | 20.556 | 3.094 | 3.593 | 2.977 | 2.911 | 5.962 | 8.150 | 2.895 |
| Total Income - EUR | 6.836 | 16.891 | 20.556 | 3.094 | 6.031 | 2.977 | 2.911 | 5.962 | 8.773 | 3.186 |
| Total Expenses - EUR | 1.070 | 2.293 | 4.440 | 3.428 | 6.741 | 2.577 | 2.162 | 3.191 | 3.805 | 1.005 |
| Gross Profit/Loss - EUR | 5.766 | 14.598 | 16.116 | -334 | -710 | 400 | 749 | 2.771 | 4.968 | 2.181 |
| Net Profit/Loss - EUR | 4.845 | 12.252 | 13.389 | -427 | -824 | 311 | 662 | 2.596 | 4.187 | 1.832 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Evomedis Invest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 6.996 | 5.377 | 3.806 | 2.287 | 827 | 0 | 5.131 | 5.734 | 5.952 |
| Current Assets | 5.834 | 10.631 | 18.786 | 4.849 | 2.643 | 714 | 4.190 | 3.581 | 1.547 | 1.948 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 539 | 18.542 | 3.862 | 2.202 | 109 | 4.062 | 2.739 | 243 | 151 |
| Cash | 5.834 | 10.092 | 245 | 987 | 440 | 605 | 128 | 842 | 1.304 | 1.797 |
| Shareholders Funds | 4.890 | 12.306 | 13.442 | -375 | -1.192 | -859 | -178 | 2.417 | 6.597 | 4.228 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 944 | 5.321 | 10.722 | 9.029 | 6.122 | 2.400 | 4.368 | 6.295 | 684 | 3.672 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7721 - 7721" | |||||||||
| CAEN Financial Year |
7721
|
|||||||||
Comments - Evomedis Invest Srl